1. Home
  2. CPAC vs QTTB Comparison

CPAC vs QTTB Comparison

Compare CPAC & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • QTTB
  • Stock Information
  • Founded
  • CPAC 1949
  • QTTB 2015
  • Country
  • CPAC Peru
  • QTTB United States
  • Employees
  • CPAC N/A
  • QTTB N/A
  • Industry
  • CPAC Building Materials
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPAC Industrials
  • QTTB Health Care
  • Exchange
  • CPAC Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • CPAC 495.3M
  • QTTB 434.0M
  • IPO Year
  • CPAC 2012
  • QTTB N/A
  • Fundamental
  • Price
  • CPAC $5.91
  • QTTB $3.43
  • Analyst Decision
  • CPAC Sell
  • QTTB Buy
  • Analyst Count
  • CPAC 1
  • QTTB 8
  • Target Price
  • CPAC $6.00
  • QTTB $29.14
  • AVG Volume (30 Days)
  • CPAC 15.2K
  • QTTB 574.0K
  • Earning Date
  • CPAC 10-29-2024
  • QTTB 11-07-2024
  • Dividend Yield
  • CPAC 8.96%
  • QTTB N/A
  • EPS Growth
  • CPAC 7.38
  • QTTB N/A
  • EPS
  • CPAC 0.12
  • QTTB N/A
  • Revenue
  • CPAC $527,798,215.00
  • QTTB N/A
  • Revenue This Year
  • CPAC N/A
  • QTTB N/A
  • Revenue Next Year
  • CPAC N/A
  • QTTB N/A
  • P/E Ratio
  • CPAC $10.04
  • QTTB N/A
  • Revenue Growth
  • CPAC N/A
  • QTTB N/A
  • 52 Week Low
  • CPAC $4.82
  • QTTB $3.35
  • 52 Week High
  • CPAC $6.65
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 47.57
  • QTTB 15.47
  • Support Level
  • CPAC $5.80
  • QTTB $21.62
  • Resistance Level
  • CPAC $6.10
  • QTTB $28.06
  • Average True Range (ATR)
  • CPAC 0.16
  • QTTB 2.38
  • MACD
  • CPAC 0.02
  • QTTB -1.81
  • Stochastic Oscillator
  • CPAC 58.70
  • QTTB 0.32

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: